---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-006777"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2026-08-28T20:05:23+00:00"
generated_at: "2026-08-28T20:08:52.664118+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma director Dr. Andrew Keller will not seek reelection

## Summary
- Dr. Andrew Keller notified company on Aug 25, 2026 he will not seek reelection.
- His term expires at the next annual shareholder meeting; no replacement named.
- Board composition will change after his departure.

## SEC filing metadata
- accession: 0001683168-26-006777
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2026-08-28T20:05:23+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316826006777/0001683168-26-006777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316826006777/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-006777
- JSON: https://secwatch.observer/filing/0001683168-26-006777.json
- Plain text: https://secwatch.observer/filing/0001683168-26-006777.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.